BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Cytosorbents Corp
CTSO
$22.7M
| $8.29M | ﹤0.01% |
2,600,437
-30,773
| -1% | -$110K |
|
3602
Flexsteel Industries
FLXS
$302M
| $8.28M | ﹤0.01% |
428,766
-12,779
| -3% | -$292K |
|
3603
iShares US Industrials ETF
IYJ
$1.98B
| $8.27M | ﹤0.01% |
78,455
+46,686
| +147% | +$4.93M |
|
|
GRNA
3604
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $8.27M | ﹤0.01% |
+858,787
| New | +$7.7M |
|
|
MILE
3605
DELISTED
Metromile, Inc. Common Stock
MILE
| $8.27M | ﹤0.01% |
6,262,376
+150,289
| +2% | +$218K |
|
3606
MoonLake Immunotherapeutics
MLTX
$1.57B
| $8.24M | ﹤0.01% |
741,906
| – | – |
|
3607
Nathan's Famous
NATH
$402M
| $8.24M | ﹤0.01% |
152,027
-3,718
| -2% | -$209K |
|
|
BFX
3608
DELISTED
BowFlex Inc.
BFX
| $8.21M | ﹤0.01% |
1,992,951
-35,252
| -2% | -$175K |
|
3609
PUT
Uber
UBER
$143B
| $8.21M | ﹤0.01% |
230,000
-470,000
| -67% | -$16.9M |
|
3610
Stantec
STN
$8.04B
| $8.19M | ﹤0.01% |
163,318
+115,326
| +240% | +$5.98M |
|
|
CLPR
3611
Clipper Realty
CLPR
$45.2M
| $8.19M | ﹤0.01% |
902,688
-45,262
| -5% | -$423K |
|
3612
NN Inc
NNBR
$255M
| $8.18M | ﹤0.01% |
2,839,594
-80,002
| -3% | -$263K |
|
3613
Vor Biopharma
VOR
$1.15B
| $8.15M | ﹤0.01% |
67,462
-2,704
| -4% | -$460K |
|
3614
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.1M
| $8.15M | ﹤0.01% |
153,868
-11,856
| -7% | -$661K |
|
3615
ZipRecruiter
ZIP
$321M
| $8.15M | ﹤0.01% |
354,539
+942
| +0.3% | +$20.4K |
|
3616
IHS Holding
IHS
$2.76B
| $8.15M | ﹤0.01% |
735,386
+352,229
| +92% | +$4.03M |
|
3617
AvePoint
AVPT
$2.76B
| $8.13M | ﹤0.01% |
1,545,996
+11,553
| +0.8% | +$66.2K |
|
|
GBL
3618
DELISTED
GAMCO Investors, Inc.
GBL
| $8.13M | ﹤0.01% |
367,732
-1,676
| -0.5% | -$37.2K |
|
|
MITT
3619
TPG Mortgage Investment Trust
MITT
$222M
| $8.13M | ﹤0.01% |
873,721
+72,462
| +9% | +$697K |
|
3620
Vertex
VERX
$2.09B
| $8.1M | ﹤0.01% |
527,967
-12,955
| -2% | -$181K |
|
|
CARM
3621
DELISTED
Carisma Therapeutics
CARM
| $8.07M | ﹤0.01% |
669,395
-5,035
| -0.7% | -$70.3K |
|
|
FM
3622
DELISTED
iShares Frontier and Select EM ETF
FM
| $8.06M | ﹤0.01% |
248,060
-20
| -0% | -$673 |
|
3623
NI Holdings
NODK
$310M
| $8.05M | ﹤0.01% |
474,965
-32,010
| -6% | -$573K |
|
3624
AquaBounty Technologies
AQB
$4.66M
| $8.04M | ﹤0.01% |
215,060
+18,180
| +9% | +$632K |
|
|
ATHX
3625
DELISTED
Athersys, Inc. Common Stock
ATHX
| $8.02M | ﹤0.01% |
529,979
-27,330
| -5% | -$572K |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.